by Melissa Rohman, Northwestern University Credit: Pixabay/CC0 Public Domain Repeat radiation therapy combined with the monoclonal antibody drug bevacizumab extended progression-free survival in patients with recurrent glioblastoma, according to findings from a recent clinical trial published in the Journal of Clinical Oncology. Jeffrey Raizer, MD, adjunct professor in the Ken and Ruth Davee Department of Neurology’s Division...
